|
Autosomal dominant polycystic kidney disease
|
127
|
4.3%
|
60.88
|
50.72/46
|
53.37/53.53
|
51.18%
|
|
Congenital anomalies of the kidney and urinary tract
|
106
|
3.6%
|
50.81
|
41.74/38
|
54.52/56.90
|
48.11%
|
|
Medullary cystic kidney disease
|
15
|
0.5%
|
7.19
|
45.87/39
|
48.65/49.27
|
60%
|
|
Thin basement membrane nephropathy
|
12
|
0.4%
|
5.75
|
82.33/91
|
51.04/57.01
|
91.67%
|
|
Alport syndrome
|
5
|
0.2%
|
2.40
|
85.4/91
|
29.46/25.61
|
80%
|
|
Tuberous sclerosis complex
|
5
|
0.2%
|
2.40
|
64.4/69
|
56.34/51.63
|
100%
|
|
Atypical hemolytic uremic syndrome
|
3
|
0.2%
|
2.40
|
45.67/44
|
36.66/41.44
|
100%
|
|
Birt-Hogg-Dube syndrome
|
3
|
0.1%
|
1.44
|
69.33/91
|
55.79/52.75
|
100%
|
|
Membranoproliferative Glomerulonephritis Type 2 (“Dense deposit disease”)
|
2
|
0.1%
|
0.96
|
48/48
|
61.25/61.25
|
50%
|
|
Fabry disease
|
2
|
0.1%
|
0.96
|
88/88
|
57.77/57.77
|
50%
|
|
Nephronophthisis
|
2
|
0.1%
|
0.96
|
40.5/40.5
|
25.46/25.46
|
50%
|
|
Familial focal segmental Glomerulosclerosis
|
2
|
0.1%
|
0.96
|
65/65
|
30.50/30.50
|
50%
|
|
Gitelman syndrome
|
1
|
0.1%
|
0.48
|
91/91
|
27.89/27.89
|
100%
|
|
Nail Patella syndrome
|
1
|
0.1%
|
0.48
|
27/27
|
30.30/30.30
|
0%
|
|
Renal tubular acidosis
|
1
|
0.1%
|
0.48
|
20/20
|
81.28/81.28
|
0%
|
|
TOTAL
|
287
|
9.8%
|
137.58
|
49.72/45
|
52.6/53.39
|
54.01%
|
